Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

Arrowhead Pharmaceuticals, Inc. bouchon mache

Volim nan komès stock Arrowhead Pharmaceuticals, Inc. jodi a ak istwa a nan lèt majiskil nan Arrowhead Pharmaceuticals, Inc. Depi nan kòmansman an nan komès nan HDP1.F aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

Arrowhead Pharmaceuticals, Inc. lèt majiskil

Jodi a lèt majiskil sou mache a nan Arrowhead Pharmaceuticals, Inc. se 4 017 275 904 Euro.
+275 706 368 € (+7.37%)
chanjman nan lèt majiskil depi yè

Arrowhead Pharmaceuticals, Inc. majiskil sou entènèt jodi a an dola. Sòm nan tout Arrowhead Pharmaceuticals, Inc. pri stock bay jodi a se lèt majiskil nan Arrowhead Pharmaceuticals, Inc. stock stock. Sit entènèt nou an pran enfòmasyon nan lèt majiskil Arrowhead Pharmaceuticals, Inc. pou jounen jodi a soti nan sous louvri. Arrowhead Pharmaceuticals, Inc., majiskil - 4 017 275 904 dola ameriken.

Arrowhead Pharmaceuticals, Inc. volim nan komès

Jodi a volim nan komès de aksyon Arrowhead Pharmaceuticals, Inc. montan 28 Euro.

Arrowhead Pharmaceuticals, Inc. volim komès jodi a se 28 dola ameriken. Arrowhead Pharmaceuticals, Inc. se tablo volim komès prezante sou sit entènèt la chak jou. Arrowhead Pharmaceuticals, Inc. komès nan tan reyèl hands sou pi echanj valè stock, sit entènèt nou an montre volim komès la chak jou nan Arrowhead Pharmaceuticals, Inc.. Arrowhead Pharmaceuticals, Inc. majiskil te ogmante pa $ 275 706 368.

Montre:
Pou

Arrowhead Pharmaceuticals, Inc. mache bouchon tablo

Arrowhead Pharmaceuticals, Inc. majiskil sou yon graf pa ane. 0% - yon chanjman nan lèt majiskil sou mache Arrowhead Pharmaceuticals, Inc. chak mwa. Pandan ane a, Arrowhead Pharmaceuticals, Inc. majiskil chanje pa 0%. Jodi a, Arrowhead Pharmaceuticals, Inc. majiskil estime nan 4 017 275 904 dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

Arrowhead Pharmaceuticals, Inc. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
04/05/2023 4 017 275 904 €
03/05/2023 3 741 569 536 €
02/05/2023 3 598 693 376 €
28/04/2023 3 630 084 608 €
27/04/2023 3 460 504 576 €
26/04/2023 3 291 540 736 €
25/04/2023 3 528 518 400 €

Arrowhead Pharmaceuticals, Inc. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

Arrowhead Pharmaceuticals, Inc. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon Arrowhead Pharmaceuticals, Inc. se kantite total tout tranzaksyon ak aksyon HDP1.F achte ak vann pandan dat la chwazi a.
04/05/2023 28 €
03/05/2023 28 €
02/05/2023 28 €
28/04/2023 28 €
27/04/2023 28 €
26/04/2023 28 €
25/04/2023 28 €

Arrowhead Pharmaceuticals, Inc. mache majiskil nan 04/05/2023 egal a 4 017 275 904 dola ameriken. Lèt majiskil sou mache Arrowhead Pharmaceuticals, Inc. montan pou 3 741 569 536 dola ameriken nan 03/05/2023. Arrowhead Pharmaceuticals, Inc. mache majiskil nan 02/05/2023 egal a 3 598 693 376 dola ameriken. Sou 28/04/2023, Arrowhead Pharmaceuticals, Inc. lèt majiskil mache a te $ 3 630 084 608.

Arrowhead Pharmaceuticals, Inc. majiskil nan 27/04/2023 montan pou 3 460 504 576 dola ameriken. Arrowhead Pharmaceuticals, Inc. majiskil nan 26/04/2023 montan pou 3 291 540 736 dola ameriken. Arrowhead Pharmaceuticals, Inc. majiskil egal a 3 528 518 400 dola ameriken nan 25/04/2023.

Lèt majiskil Arrowhead Pharmaceuticals, Inc. jodi a se 4 017 275 904 €. Kapitalizasyon sou mache a nan Arrowhead Pharmaceuticals, Inc. te chanje a +7.37% konpare ak yè. Volim komèsyal de aksyon HDP1.F nan Arrowhead Pharmaceuticals, Inc. nan dènye jou komès montan pou 28 €. Volim komèsyal de aksyon de Arrowhead Pharmaceuticals, Inc. chanje pou 0% konpare ak jou komès anvan an.

Pri a de aksyon Arrowhead Pharmaceuticals, Inc.

Finans Arrowhead Pharmaceuticals, Inc.